Affymetrix's Q1 Revenues Drop 8 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Affymetrix reported after the close of the market on Wednesday that its first-quarter revenues slid 8 percent, but the company recorded a modest profit.

For the three months ended March 31, the Santa Clara, Calif.-based microarray company recorded revenues of $73.7 million, down from $80.2 million a year ago and missing analyst estimates of $75.8 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: SNP reference panel from the Haplotype Reference Consortium, and more.

Halloran Consulting's Laurie Halloran lists at Stat News the mistakes she sees startup companies make when pursuing a clinical trial.

MIT researchers are using bees to collect and visualize urban microbiome samples, Wired reports.

Reliance on Excel leads to errors in gene name lists, a new Genome Biology paper reports.